Telmisartan - Boehringer Ingelheim/GlaxoSmithKline
At a glance
- Drug Originator Boehringer Ingelheim Pharma KG
- Drug Licenced by Bayer; Glenmark Pharmaceuticals Ltd; GSK; Nippon Boehringer Ingelheim
- Drug Class Antihypertensives; Benzimidazoles; Benzoates; Small molecules
- Mechanism of Action ACE inhibitors; Angiotensin type 2 receptor antagonists
- USA Patent Applicants BOEHRINGER INGELHEIM
- USA Patents 4
- NDAs 1
- Patent Applications 4,727
Table of Contents

Disclaimer